CONFERENCES
ISRAEL NEWS
HEALTH & WELLNESS
WORLD NEWS
MIDDLE EAST
BUSINESS & INNOVATION
OPINION
JP STORE
Login
Login
Subscribe
JPOST DIGITAL LIBRARY
HOME PAGE
BUSINESS & INNOVATION
OPINION
REAL ESTATE LISTINGS
ALIYAH
JERUSALEM POST CONFERENCE
PREMIUM
JP STORE
Categories
ISRAEL NEWS
WORLD NEWS
MIDDLE EAST
ARAB ISRAELI CONFLICT
US POLITICS
DIASPORA
OPINION
PODCAST
JUDAISM
KABBALAH
CHRISTIAN WORLD
HEALTH & WELLNESS
SCIENCE
LAW
ARCHAEOLOGY
OMG
ENVIRONMENT & CLIMATE CHANGE
FOOD & RECIPES
JERUSALEM POST EN ESPANOL
HISTORY
SPONSORED CONTENT
ADVERTISE WITH US
TERMS OF USE
PRIVACY POLICY
CONTACT US
CANCEL SUBSCRIPTION
CUSTOMER SERVICE
ABOUT US
Jerusalem Post
/
Health & Wellness
86-year-old Copaxone creator has no intention of slowing down
When it comes to being excited by experiments, age is simply not a factor for 86-year-old Prof. Ruth Arnon, co-creator of multiple sclerosis drug Copaxone.
Professor Ruth Arnon, who was awarded the 2020 OurCrowd Maimonides Award for Lifetime Achievement in Science, Leadership and Menschlichkeit at the OurCrowd Global Investor Summit. February 13, 2020.
(photo credit:
MARC ISRAEL SELLEM
)
By
EYTAN HALON
FEBRUARY 13, 2020 22:15
See more on
Pharmaceuticals
|
Multiple Sclerosis
RECOMMENDED STORIES
North Korea to send 30,000 soldiers to frontlines as Washington weighs support for Ukraine
JULY 2, 2025
Three rockets of unknown origin fall in Iraq, Iranian media claim five drone strikes
JULY 1, 2025
'They shoot people deliberately': Gazans testify that Hamas intentionally targets aid sites
JULY 1, 2025
Mossad to Tehran: We already know your ‘secret’ war commander
JULY 1, 2025
Hot Opinion
In Washington, Netanyahu must prioritize bringing home hostages before Iran
By
JPOST EDITORIAL
A dangerous new chapter: The threat of North American domestic terror
By
MICHAEL MASTERS
An Iron Dome of values: Israel's future lies in Herzl's vision
By
IRINA NEVZLIN
Poor habits cause death more than disease
By
ALAN FREISHTAT
